# HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/her2-amplification-in-advanced-nsclc-patients-after-progression-on-egfr-tki-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jiadi Gan,Yihua Huang,Jun Liao,Lanlan Pang,Wenfeng Fang |
| Citations | 24 |
| DOI | 10.2147/ott.s335217 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.dovepress.com/getfile.php?fileID=75958 |
| OpenAlex ID | https://openalex.org/W3213227438 |
| PMID | 34824536 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Lanlan Pang](https://scholariq.org/researchers/lanlan-pang/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.